Crucible · Firm report card
KARYOPHARM THERAPEUTICS INC.
MA · SBIR awardee across 1 federal program (HHS/NIH), first award 2016.
2SBIR awards
$2MSBIR $
1 → 1Phase I → II
$0Follow-on federal $
1Follow-on contracts
SBIR awards by program
| Program | Awards | SBIR $ | Phase I | Phase II |
|---|---|---|---|---|
| HHS/NIH | 2 | $2M | 1 | 1 |
Mission areas
Open the interactive profile of KARYOPHARM THERAPEUTICS INC. →Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.
Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology